Emergence of new virulent neisseria meningitidis serogroup C sequence type 11 isolates in France

Journal of Infectious Diseases

Volumn 202, Issue 2, 2010, Pages 247-250

  Deghmane, Ala Eddine ^a,c,d   Du Chatelet, Isabelle Parent ^b   Szatanik, Marek ^a,c,d   Hong, Eva ^a,c,d   Ruckly, Corinne ^a,c,d   Giorgini, Dario ^a,c,d   Lévy Bruhl, Daniel ^a   Alonso, Jean Michel ^c,d   Taha, Muhamed Kheir ^a,c,d  

^a Invasive Bacterial Infections Unit   (France)

^b INSTITUT DE VEILLE SANITAIRE   (France)

^c Neisseria Unit   (France)

^d INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; CHILD; FEMALE; FRANCE; GENE SEQUENCE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROTYPE; VIRULENCE; ANIMAL; CLASSIFICATION; CLONOGENIC ASSAY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EPIDEMIC MENINGITIS; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PATHOGENICITY; PHENOTYPE; STATISTICS; TRANSGENIC MOUSE;

BACTERIAL VACCINE; TRANSFERRIN;

ANIMALS; BACTERIAL VACCINES; COLONY-FORMING UNITS ASSAY; DISEASE MODELS, ANIMAL; DISEASE OUTBREAKS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FRANCE; HUMANS; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL INFECTIONS; MICE; MICE, TRANSGENIC; NEISSERIA MENINGITIDIS; PHENOTYPE; TRANSFERRIN;

EID: 77954588473     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/653583     Document Type: Article

References (14)

1. Trotter CL, Ramsay ME. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines. FEMS Microbiol Rev 2007; 31:101-107.
2. Levy-Bruhl D, Perrocheau A, Mora M, et al. Vaccination campaign following an increase in incidence of serogroup C meningococcal dis eases in the department of Puy-de-Dome (France). Euro Surveill 2002; 7:74-76.
3. Maiden MC, Bygraves JA, Feil E, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 1998; 95:3140-3145.
4. Taha MK, Giorgini D, Ducos-Galand M, Alonso JM. Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000. J Clin Microbiol 2004; 42:4158-4163.
5. Zarantonelli ML, Szatanik M, Giorgini D, et al. Transgenic mice expressing human transferrin as a model for meningococcal infection. Infect Immun 2007; 75:5609-5614.
6. Zarantonelli ML, Lancellotti M, Deghmane AE, et al. Hyperinvasive genotypes of Neisseria meningitidis in France. Clin Microbiol Infect 2008; 14:467-472.
7. Vogel U, Claus H, Frosch M, Caugant DA. Molecular basis for distinction of the ET-15 clone within the ET-37 complex of Neisseria meningitidis. J Clin Microbiol 2000; 38:941-942.
8. Trotter CL, Fox AJ, Ramsay ME, et al. Fatal outcome from meningococcal disease-an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin. J Med Microbiol 2002; 51:855-860.
9. Perrocheau A, Taha MK, Levy-Bruhl D. Epidemiology of invasive meningococcal disease in France in 2003. Euro Surveill 2005; 10:238-241.
10. Bonmarin I, Lévy-Bruhl D. Group C meningococcus vaccination in the southwest region of France. Euro Surveill 2002; 6:article 4. http:// www.eurosurveillance.org/ViewArticle.aspx?ArticleIdp1920.
11. Tsang RS, Tsai CM, Zhu P, Ringuette L, Lorange M, Law DK. Phenotypic and genetic characterization of a unique variant of serogroup C ET-15 meningococci (with the antigenic formula C:2a:P1.7,1) causing invasive meningococcal disease in Quebec, Canada. J Clin Microbiol 2004; 42:1460-1465.
12. Tribe DE, Zaia AM, Griffith JM, et al. Increase in meningococcal disease associated with the emergence of a novel ST-11 variant of serogroup C Neisseria meningitidis in Victoria, Australia, 1999-2000. Epidemiol Infect 2002; 128:7-14.
13. Taha MK, Bichier E, Perrocheau A, Alonso JM. Circumvention of herd immunity during an outbreak of meningococcal disease could be correlated to escape mutation in the porA gene of Neisseria meningitidis. Infect Immun 2001; 69:1971-1973.
14. Zarantonelli ML, Huerre M, Taha MK, Alonso JM. Differential role of lipooligosaccharide of Neisseria meningitidis in virulence and inflammatory response during respiratory infection in mice. Infect Immun 2006; 74:5506-5512.